A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis


Study Number
46517
Phase
2
Purpose

The purpose of this study is to evaluate the safety, tolerability, and efficacy of the combination of parsaclisib and ruxolitinib in subjects with myelofibrosis.

Full Title

A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

ClinicalTrials.Gov ID
NCT02718300

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.